ICAAC 40th

Title Content type
An Open, Non-Comparative Multicenter Study to Evaluate Efficacy and Safety of Posaconazole (SCH 56592) in the Treatment of Invasive Fungal Infections (IFI) Refractory (R) to or Intolerant (I) to Standard Therapy (ST). (click for details)
In Vivo Studies of Antifungal Agents (click for details)
Multicenter, Noncomparative Study to Evaluate Safety and Efficacy of Caspofungin (CAS) in Adults with Invasive Aspergillosis (IA) Refractory (R) or Intolerant (I) to Amphotericin B (AMB), AMB Lipid Formulations (Lipid AMB), or Azoles. (click for details)
Practice Guidelines, IDSA, for Aspergillosis. (click for details)
A Comparative Study of the In Vitro Susceptibility of Aspergillus fumigatus to Antifungal Agents Individually and in Combinations by the Fractional Inhibitory Concentration Index, Tetrazolium Reduction and Radiometric Assays. (click for details)
Detection of Rhinovirus RNA in Bronchoalveolar Lavage in Hematopoietic Stem Cell Transplant Recipients with Pneumonia. (click for details)
The Isolation of Aspergillus fumigatus after Heart Transplantation is Highly Predictive of Invasive Aspergillosis. (click for details)
Pharmacokinetics and Pharmacodynamics of Posaconazole (SCH 56592) in a Neutropenic Animal Model of Invasive Pulmonary Aspergillosis. (click for details)
Real-time antifungal susceptibility screening aids management of invasive yeast infections in immunocompromised patients (click for details)
Rapid Detection of Candida and Aspergillus spp. Using Molecular Beacons. (click for details)


Subscribe to ICAAC 40th